Researchers crack key HIV riddle after decades
February 1st, 2010 - 2:35 pm ICT by IANSLondon, Feb 1 (IANS) Researchers have cracked a key riddle that has foxed scientists for decades, potentially opening the way to better treatment of HIV, says a new study.
Imperial College London and Harvard University researchers have grown a crystal that reveals the structure of an enzyme called integrase, which is found in retroviruses like HIV.
When HIV infects someone, it uses integrase to paste a copy of its genetic information into their DNA.
Prior to the new study, funded by the Medical Research Council and the US National Institutes of Health, many researchers had tried and failed to work out the 3-D structure of integrase bound to viral DNA.
New antiretroviral drugs for HIV work by blocking integrase, but scientists did not understand exactly how these drugs were working or how to improve them.
Researchers can only determine the structure of this kind of molecular machinery by obtaining high quality crystals.
For the new study, researchers grew a crystal using a version of integrase borrowed from a little-known retrovirus called Prototype Foamy Virus (PFV). Based on their knowledge of PFV integrase and its function, they were confident that it was very similar to its HIV counterpart.
Over the course of four years, the researchers carried out over 40,000 trials, out of which they were able to grow just seven kinds of crystals. Only one of these was of sufficient quality to allow determination of the 3-D structure.
Peter Cherepanov, who led the study at the Department of Medicine at Imperial College, said: “It is a truly amazing story. When we started out, we knew that the project was very difficult, and that many tricks had already been tried and given up by others long ago.”
“Therefore, we went back to square one and started by looking for a better model of HIV integrase, which could be more amenable for crystallisation,” said Cherepanov, according to an Imperial College release.
“Despite initially painstakingly slow progress and very many failed attempts, we did not give up and our effort was finally rewarded,” he added.
The study was published in Nature.
- Breakthrough may lead to new HIV drugs - Feb 01, 2010
- Cancer drug successfully purges hidden HIV virus - Mar 09, 2012
- New approach for targeted killing of HIV virus - Aug 19, 2010
- Vaginal gel could offer protection against HIV - May 24, 2010
- Enzyme crucial to DNA replication may be potent anti-cancer drug target - Apr 15, 2011
- 6-month drug regimen 'reduces HIV risk for breastfeeding infants' - Mar 03, 2011
- Study offers potential new targets for novel anti-HIV drugs - Mar 26, 2011
- HIV replication process could be different than previously thought - Jul 16, 2010
- Complete structure of HIV's outer shell revealed - Jan 20, 2011
- Standard re-treatment regimen for TB 'failing' in developing world - Mar 16, 2011
- Protein knocks out HIV by starving it of raw materials - Feb 13, 2012
- Ranbaxy's South African arm bags $133 million order - Dec 20, 2010
- Gene-based controls 'could stop mosquitoes spreading malaria' - Apr 21, 2011
- Insight into structure of HIV protein may help design drugs - Jun 10, 2010
- Frequent alcohol use fans faster HIV spread - May 14, 2010
Tags: antiretroviral drugs, cherepanov, counterpart, foamy virus, genetic information, harvard university researchers, hiv, hiv integrase, imperial college london, london feb, medical research council, molecular machinery, national institutes of health, prototype, quality crystals, retroviruses, riddle, study researchers, treatment of hiv, viral dna